and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Corbus Pharmaceuticals Holdings Stock Price (Quote) NASDAQ:CRBP
$0.27 ( 4.53% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.22 | $0.32 | Tuesday, 5th Jul 2022 CRBP stock ended at $0.27. This is 4.53% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 9.75% from a day low at $0.25 to a day high of $0.28. |
| 90 days | $0.21 | $0.49 | |
| 52 weeks | $0.21 | $1.79 |
Historical Corbus Pharmaceuticals Holdings prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $0.26 | $0.28 | $0.25 | $0.27 | 243 709 |
| 2022-07-01 | $0.26 | $0.27 | $0.26 | $0.26 | 176 606 |
| 2022-06-30 | $0.26 | $0.27 | $0.25 | $0.25 | 404 447 |
| 2022-06-29 | $0.28 | $0.28 | $0.25 | $0.25 | 837 482 |
| 2022-06-28 | $0.27 | $0.29 | $0.26 | $0.27 | 506 331 |
| 2022-06-27 | $0.27 | $0.29 | $0.26 | $0.27 | 765 196 |
| 2022-06-24 | $0.30 | $0.31 | $0.25 | $0.25 | 965 167 |
| 2022-06-23 | $0.29 | $0.29 | $0.27 | $0.28 | 531 949 |
| 2022-06-22 | $0.29 | $0.29 | $0.27 | $0.28 | 331 415 |
| 2022-06-21 | $0.29 | $0.30 | $0.27 | $0.29 | 556 003 |
| 2022-06-17 | $0.25 | $0.30 | $0.23 | $0.30 | 1 065 559 |
| 2022-06-16 | $0.26 | $0.27 | $0.22 | $0.23 | 951 269 |
| 2022-06-15 | $0.25 | $0.27 | $0.25 | $0.26 | 590 204 |
| 2022-06-14 | $0.27 | $0.28 | $0.25 | $0.25 | 473 992 |
| 2022-06-13 | $0.29 | $0.29 | $0.26 | $0.26 | 614 798 |
| 2022-06-10 | $0.30 | $0.31 | $0.28 | $0.29 | 657 272 |
| 2022-06-09 | $0.29 | $0.32 | $0.28 | $0.30 | 727 502 |
| 2022-06-08 | $0.28 | $0.30 | $0.28 | $0.29 | 426 862 |
| 2022-06-07 | $0.30 | $0.31 | $0.27 | $0.28 | 916 335 |
| 2022-06-06 | $0.31 | $0.31 | $0.28 | $0.30 | 247 926 |
| 2022-06-03 | $0.29 | $0.31 | $0.29 | $0.30 | 414 764 |
| 2022-06-02 | $0.30 | $0.30 | $0.29 | $0.29 | 355 694 |
| 2022-06-01 | $0.30 | $0.32 | $0.27 | $0.30 | 1 675 431 |
| 2022-05-31 | $0.30 | $0.31 | $0.29 | $0.30 | 1 220 804 |
| 2022-05-27 | $0.30 | $0.30 | $0.29 | $0.30 | 471 011 |
| 2022-05-26 | $0.30 | $0.31 | $0.29 | $0.30 | 986 350 |
| 2022-05-25 | $0.32 | $0.33 | $0.29 | $0.30 | 708 373 |
| 2022-05-24 | $0.32 | $0.33 | $0.30 | $0.31 | 412 150 |
| 2022-05-23 | $0.32 | $0.33 | $0.30 | $0.31 | 1 084 047 |
| 2022-05-20 | $0.35 | $0.36 | $0.32 | $0.34 | 1 281 471 |
| 2022-05-19 | $0.33 | $0.36 | $0.33 | $0.35 | 1 301 291 |
| 2022-05-18 | $0.31 | $0.35 | $0.29 | $0.33 | 3 227 485 |
| 2022-05-17 | $0.28 | $0.31 | $0.28 | $0.30 | 1 604 025 |
| 2022-05-16 | $0.25 | $0.41 | $0.23 | $0.30 | 30 735 323 |
| 2022-05-13 | $0.23 | $0.24 | $0.21 | $0.21 | 5 002 306 |
| 2022-05-12 | $0.23 | $0.24 | $0.21 | $0.21 | 2 111 918 |
| 2022-05-11 | $0.27 | $0.28 | $0.23 | $0.24 | 682 603 |
| 2022-05-10 | $0.30 | $0.30 | $0.25 | $0.26 | 817 432 |
| 2022-05-09 | $0.31 | $0.31 | $0.26 | $0.27 | 898 088 |
| 2022-05-06 | $0.32 | $0.32 | $0.29 | $0.29 | 955 666 |
| 2022-05-05 | $0.33 | $0.34 | $0.32 | $0.32 | 382 004 |
| 2022-05-04 | $0.35 | $0.35 | $0.32 | $0.33 | 443 547 |
| 2022-05-03 | $0.34 | $0.35 | $0.33 | $0.34 | 276 040 |
| 2022-05-02 | $0.34 | $0.34 | $0.32 | $0.34 | 355 978 |
| 2022-04-29 | $0.34 | $0.35 | $0.33 | $0.34 | 201 776 |
| 2022-04-28 | $0.35 | $0.36 | $0.32 | $0.35 | 355 526 |
| 2022-04-27 | $0.34 | $0.36 | $0.33 | $0.34 | 551 270 |
| 2022-04-26 | $0.34 | $0.35 | $0.33 | $0.33 | 544 667 |
| 2022-04-25 | $0.36 | $0.37 | $0.33 | $0.35 | 717 913 |
| 2022-04-22 | $0.37 | $0.38 | $0.35 | $0.35 | 389 831 |
Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. Its lead product candidate includes Resunab, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of cystic fibrosis, systemic sclerosis, and skin-predominant dermatomyositis diseases. The company is based in N... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
